血浆循环miR-23~27~24簇与1型糖尿病儿童免疫代谢紊乱相关并预测C肽丢失
研究分析了1型糖尿病儿童血浆循环microRNA与免疫代谢谱的关联,并识别能预测疾病进展的复合签名。血浆miR-23~27~24簇在1型糖尿病进展中上调,与骨保护素(OPG)正相关,与可溶性CD40配体等负相关。miR-23a-3p/miR-23b-3p/miR-24-3p/miR-27b-3p/OPG组合在诊断时显著预测12个月后胰岛素分泌下降。
要点
- 血浆miR-23~27~24簇在1型糖尿病进展中上调。
- miR-23~27~24簇与OPG正相关,与sCD40L、抵抗素、MPO、sTNFR负相关。
- miR-23a-3p/miR-23b-3p/miR-24-3p/miR-27b-3p/OPG组合可预测12个月后胰岛素分泌下降。
核心结论
- 识别出新的miR-23a-3p/miR-23b-3p/miR-24-3p/miR-27b-3p/OPG血浆签名,可能开发为基于血液的新方法,以更好地对1型糖尿病患者进行分层并预测C肽丢失。
研究设计与样本
- 研究纳入1型糖尿病诊断时儿童(n=88)、诊断后12个月(n=32)和24个月(n=30)的儿童,以及性别和年龄分布相似的健康对照儿童(n=47)。
- 通过定量RT-PCR量化60个稳健表达的血浆循环miRNA,并用血浆免疫代谢因子检测9个指标。
- 根据空腹C肽丢失将1型糖尿病儿童分层:C肽丢失>90%组、C肽丢失<10%组和中间C肽丢失组。
- 结果在近期起病1型糖尿病儿童的独立队列(n=18)中验证,并用基于神经网络的模型测试血浆签名的预后价值。
主要发现
- 血浆循环miR-23~27~24簇(miR-23a-3p、miR-23b-3p、miR-24-3p、miR-27a-3p和miR-27b-3p)在1型糖尿病进展中上调。
- 在1型糖尿病儿童中,miR-23~27~24簇与骨保护素(OPG)正相关,与可溶性CD40配体、抵抗素、髓过氧化物酶和可溶性TNF受体负相关,但在健康儿童中无此相关性。
- 在疾病诊断时定量的血浆循环miR-23a-3p、miR-23b-3p、miR-24-3p、miR-27b-3p和OPG组合,在两个独立的1型糖尿病儿童队列中显示出显著预测疾病诊断后12个月胰岛素分泌下降的能力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: We aimed to analyse the association between plasma circulating microRNAs (miRNAs) and the immunometabolic profile in children with type 1 diabetes and to identify a composite signature of miRNAs/immunometabolic factors able to predict type 1 diabetes progression. METHODS: Plasma samples were obtained from children at diagnosis of type 1 diabetes (n = 88) and at 12 (n = 32) and 24 (n = 30) months after disease onset and from healthy control children with similar sex and age distribution (n = 47). We quantified 60 robustly expressed plasma circulating miRNAs by quantitative RT-PCR and nine plasma immunometabolic factors with a recognised role at the interface of metabolic and immune alterations in type 1 diabetes. Based on fasting C-peptide loss over time, children with type 1 diabetes were stratified into the following groups: those who had lost >90% of C-peptide compared with diagnosis level; those who had lost <10% of C-peptide; those showing an intermediate C-peptide loss. To evaluate the modulation of plasma circulating miRNAs during the course of type 1 diabetes, logistic regression models were implemented and the correlation between miRNAs and immunometabolic factors was also assessed. Results were then validated in an independent cohort of children with recent-onset type 1 diabetes (n = 18). The prognostic value of the identified plasma signature was tested by a neural network-based model. RESULTS: Plasma circulating miR-23~27~24 clusters (miR-23a-3p, miR-23b-3p, miR-24-3p, miR-27a-3p and miR-27b-3p) were upmodulated upon type 1 diabetes progression, showed positive correlation with osteoprotegerin (OPG) and were negatively correlated with soluble CD40 ligand, resistin, myeloperoxidase and soluble TNF receptor in children with type 1 diabetes but not in healthy children. The combination of plasma circulating miR-23a-3p, miR-23b-3p, miR-24-3p, miR-27b-3p and OPG, quantified at disease onset, showed a significant capability to predict the decline in insulin secretion 12 months after disease diagnosis in two independent cohorts of children with type 1 diabetes. CONCLUSIONS/INTERPRETATIONS: We have pinpointed a novel miR-23a-3p/miR-23b-3p/miR-24-3p/miR-27b-3p/OPG plasma signature that may be developed into a novel blood-based method to better stratify patients with type 1 diabetes and predict C-peptide loss.
引用
- Garavelli S, Bruzzaniti S, Tagliabue E, et al. Plasma circulating miR-23~27~24 clusters correlate with the immunometabolic derangement and predict C-peptide loss in children with type 1 diabetes. Diabetologia. 2020. PMID: 32728892. doi:10.1007/s00125-020-05237-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。